Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Author(s): Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Issue: Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue
Page(s): 461-467
Download in electronic PDF format for $75
Abstract: Extemporaneous drug formulation is essential to provide optimal pharmaceutical care to veterinary patients. The need for this is exacerbated by the fact that commercially produced veterinary-specific products, without a human indication, require specialty veterinary manufacturing facilities and a new animal drug application process to gain marketing approval. This study examined the prescription patterns of extemporaneously compounded veterinary preparations in the compounding department at a large independent community pharmacy. Data was obtained from a total of 1348 prescriptions requiring extemporaneous compounding over the course of a two-year period (2014–2015). A database was constructed and each compounded prescription was allocated to a therapeutic category based on the American Hospital Formulary Service Drug Information. Data analysis showed that the most commonly prescribed preparations belonged to the central nervous system (39%), anti-infective agents (21%), and hormones (12%) therapeutic categories. Overall, suspensions were the most dispensed (47%), extemporaneously compounded dosage forms followed by solutions (28%), and capsules (10%). The majority (88%) of compounded preparations were administered by the oral route. The top three drugs that are compounded for veterinary medicine were (1) potassium bromide oral solution for canine epilepsy, (2) methimazole solution used to treat hyperthyroidism in cats, and (3) metronidazole suspension, an antibiotic for the treatment of diarrhea and other infections in dogs and cats. Remarkably, our findings are in good agreement with previously published survey data on the top drugs that are compounded for veterinary medicine. In the era of personalized medicine, veterinary extemporaneous compounding for specialized needs will continue to play an important role providing optimum therapy for veterinary patients.
Related Keywords:
veterinary compounding, species, drug classes, therapeutic categories, dosage forms, central nervous system agents, CNS, anti-infective agents, antibiotics, antimicrobial agents, antifungal agents, hormones, route of administration, seizures, hyperthyroidism, bacterial infection
Related Categories:
VETERINARY, DOSAGE FORMS/DRUG CARRIERS, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, INFECTIOUS DISEASE, NEUROLOGY
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Veterinary Transdermal Medications: A to Z
Davidson Gigi S
|
Mar/Apr 2003
Pg. 106-113
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy
Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
|
Nov/Dec 2016
Pg. 461-467
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula
Sherr Zachary, Karara Adel H
|
Nov/Dec 2014
Pg. 462-468
|
Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R, Newton Gail D
|
May/Jun 2004
Pg. 181-185
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
The Current Landscape of Veterinary Compounding in the Pharmacy Setting
Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
|
Sep/Oct 2019
Pg. 422-427
|
The Current Landscape of Veterinary Compounding in the Veterinary Setting
Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
|
Sep/Oct 2019
Pg. 428-433
|
Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms
Akers Michael J
|
Jan/Feb 2017
Pg. 47-56
|
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Davidson Gigi S
|
Jul/Aug 2001
Pg. 282-283
|
Pain: Systematic Review of Pharmacy Compounding of Pain Medication
Shawaqfeh Mohammad S, Harrington Catherine
|
Jan/Feb 2018
Pg. 19-24
|
Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy
Kochanowska-Karamyan Anna J
|
Sep/Oct 2016
Pg. 367-374
|
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports
Haase Mark R, Luedtke Sherry, Robles Janie, Parker Thomas, Leff Rich, Giacoia George
|
Jan/Feb 2009
Pg. 14-18
|
Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 2001
Pg. 310-312
|
The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
|
Mar/Apr 2001
Pg. 86-88
|
E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy
Reed-Kane Dana, Vasquez Kellie, Pavlik Aaron, Pergine Johanna, Sandberg Michelle
|
Mar/Apr 2014
Pg. 159-161
|
Basics of Sterile Compounding: Sterile Product Packaging and Delivery Systems
Akers Michael J
|
Nov/Dec 2015
Pg. 491-500
|
Pharmaceutical Compounding in Portuguese Community Pharmacies: Characterization and Future Perspectives
Palmeira-de-Oliveira Rita, Macedo Marina, Machado Rita M, Pacheco Ana Filipa, Palmeira-de-Oliveira Ana, Martinez-de-Oliveira José, Duarte Paulo
|
Mar/Apr 2016
Pg. 114-122
|
When to Compound Medications for Veterinary Patients
Forsythe Lauren Eichstadt
|
Jan/Feb 2017
Pg. 19-21
|
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2
Davidson Gigi S
|
Jul/Aug 2004
Pg. 277-283
|
United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine
DeVeau Ian
|
Sep/Oct 2007
Pg. 357-362
|
Return to Top |